Year |
Citation |
Score |
2020 |
Ghosh S, Das T, Suman SK, Kumar C, Sarma HD, Dash A. Targeted Tumor Therapy with Radiolabeled DNA Intercalator: A Possibility? Preclinical Investigations with Lu-Acridine. Biomed Research International. 2020: 9514357. PMID 32775454 DOI: 10.1155/2020/9514357 |
0.346 |
|
2020 |
Ghosh S, Das T, Suman SK, Sarma HD, Dash A. Preparation and Preliminary Evaluation of 68Ga-Acridine: An Attempt to Study the Potential of Radiolabeled DNA Intercalator as a PET Radiotracer for Tumor Imaging. Anti-Cancer Agents in Medicinal Chemistry. PMID 32357824 DOI: 10.2174/1871520620666200502002609 |
0.369 |
|
2020 |
Lohar S, Jadhav S, Chakravarty R, Chakraborty S, Sarma HD, Dash A. A kit based methodology for convenient formulation of Ho-Chitosan complex for treatment of liver cancer. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 161: 109161. PMID 32250846 DOI: 10.1016/J.Apradiso.2020.109161 |
0.327 |
|
2020 |
Satpati D, Vats K, Sharma R, Sarma HD, Dash A. Ga-labeling of internalizing RGD (iRGD) peptide functionalized with DOTAGA and NODAGA chelators. Journal of Peptide Science : An Official Publication of the European Peptide Society. e3241. PMID 31984553 DOI: 10.1002/Psc.3241 |
0.362 |
|
2019 |
Vats K, Agrawal K, Sharma R, Sarma HD, Satpati D, Dash A. Preparation and clinical translation of Tc-PSMA-11 for SPECT imaging of prostate cancer. Medchemcomm. 10: 2111-2117. PMID 32190233 DOI: 10.1039/C9Md00401G |
0.338 |
|
2019 |
Guleria M, Das T, Amirdhanayagam J, Sarma HD, Dash A. Preparation of [Lu]Lu-DOTA-Ahx-Lys40-Exendin-4 for radiotherapy of insulinoma: a detailed insight into the radiochemical intricacies. Nuclear Medicine and Biology. 78: 31-40. PMID 31731177 DOI: 10.1016/J.Nucmedbio.2019.11.003 |
0.329 |
|
2019 |
Satpati D, Vats K, Sharma R, Kameswaran M, Sarma HD, Dash A. Synthesis, Radiolabeling and Evaluation of GRPr Antagonist Ga-HBED-CC-RM26. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 31378967 DOI: 10.1002/Jlcr.3795 |
0.329 |
|
2019 |
Chakraborty S, Das S, Chakravarty R, Sarma HD, Vatsa R, Shukla J, Mittal BR, Dash A. An improved kit formulation for one pot synthesis of [ Tc]Tc-HYNIC-E[c (RGDfK)] for routine clinical use in cancer imaging. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 31315149 DOI: 10.1002/Jlcr.3786 |
0.414 |
|
2019 |
Vats K, Sharma R, Kameswaran M, Sarma HD, Satpati D, Dash A. Design, synthesis, and comparative evaluation of Tc(CO) -labeled N-terminal and C-terminal modified asparagine-glycine-arginine peptide constructs. Journal of Peptide Science : An Official Publication of the European Peptide Society. 25: e3192. PMID 31309677 DOI: 10.1002/Psc.3192 |
0.348 |
|
2019 |
Guleria M, Das T, Vats K, Amirdhanayagam J, Mathur A, Sarma HD, Dash A. Preparation and evaluation of Tc-labeled porphyrin complexes prepared using PNP and HYNIC cores: studying the effects of core selection on pharmacokinetics and tumor uptake in a mouse model. Medchemcomm. 10: 606-615. PMID 31057740 DOI: 10.1039/C8Md00559A |
0.369 |
|
2019 |
Kameswaran M, Pandey U, Gamre N, Sarma HD, Dash A. Preparation of Lu-Trastuzumab injection for treatment of breast cancer. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 148: 184-190. PMID 30974402 DOI: 10.1016/J.Apradiso.2019.04.002 |
0.311 |
|
2019 |
Das S, Sakhare N, Mathur A, Mallia MB, Mirapurkar S, Sheela M, Sarma HD, Sachdev SS, Dash A. Synthesis and evaluation of Tc-analogues of [I]mIBG prepared via [Tc][Tc(CO)(HO)] synthon for targeting norepinephrine transporter. Nuclear Medicine and Biology. PMID 30770228 DOI: 10.1016/J.Nucmedbio.2019.01.001 |
0.365 |
|
2019 |
Vimalnath KV, Rajeswari A, Sarma HD, Dash A, Chakraborty S. Ce-141-labeled DOTMP: A theranostic option in management of pain due to skeletal metastases. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 30663098 DOI: 10.1002/Jlcr.3710 |
0.361 |
|
2019 |
Kumar C, Sharma R, Vats K, Mallia MB, Das T, Sarma HD, Dash A. Comparison of the efficacy of 177 Lu-EDTMP, 177 Lu-DOTMP and 188 Re-HEDP towards bone osteosarcoma: an in vitro study Journal of Radioanalytical and Nuclear Chemistry. 319: 51-59. DOI: 10.1007/S10967-018-6283-5 |
0.334 |
|
2018 |
Mukherjee A, Korde A, Shinto A, Sarma HD, Kamaleswaran K, Dash A. Studies on batch formulation of a freeze dried kit for the preparation of Tc-HYNIC-TATE for imaging neuroendocrine tumors. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 145: 180-186. PMID 30639635 DOI: 10.1016/J.Apradiso.2018.12.027 |
0.36 |
|
2018 |
Das S, Mathur A, Sakhare N, Mallia MB, Sarma HD, Sachdev SS, Dash A. Synthesis and Biodistribution studies of Tc labeled fatty acid derivatives prepared via 'Click approach' for potential use in cardiac imaging. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 30171704 DOI: 10.1002/Jlcr.3681 |
0.376 |
|
2018 |
Guleria M, Kumar C, Das T, Amirdhanayagam J, Sharma R, Sarma HD, Dash A. Studies towards elucidating the potential of 5,10,15,20-tetrakis(-carboxy-methyleneoxyphenyl)porphyrin as a theranostic agent for applications in PET and PDT. Medchemcomm. 9: 657-666. PMID 30108956 DOI: 10.1039/C7Md00433H |
0.412 |
|
2018 |
Mukherjee A, Bhatt J, Shinto A, Korde A, Kumar M, Kamaleshwaran K, Joseph J, Sarma HD, Dash A. Ga-NOTA-ubiquicidin fragment for PET imaging of infection: From bench to bedside. Journal of Pharmaceutical and Biomedical Analysis. 159: 245-251. PMID 29990892 DOI: 10.1016/J.Jpba.2018.06.064 |
0.324 |
|
2018 |
Jain A, Mathur A, Pandey U, Sarma HD, Dash A. Synthesis and evaluation of Ga labeled palmitic acid for cardiac metabolic imaging. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 140: 35-40. PMID 29936274 DOI: 10.1016/J.Apradiso.2018.06.003 |
0.341 |
|
2018 |
Chakraborty S, Goswami D, Chakravarty R, Mohammed SK, Sarma HD, Dash A. Syntheses and evaluation of Ga- and Sm-labeled DOTA-conjugated bisphosphonate ligand for potential use in detection of skeletal metastases and management of pain arising from skeletal metastases. Chemical Biology & Drug Design. PMID 29729071 DOI: 10.1111/Cbdd.13327 |
0.397 |
|
2018 |
Jain A, Chakraborty S, Sarma HD, Dash A. A Systematic Comparative Evaluation of Ga-Labeled RGD Peptides Conjugated with Different Chelators. Nuclear Medicine and Molecular Imaging. 52: 125-134. PMID 29662561 DOI: 10.1007/S13139-017-0499-0 |
0.339 |
|
2018 |
Vats K, Sharma R, Sarma HD, Satpati D, Dash A. 68Ga-labeled HBED-CC variant of uPAR targeting peptide AE105 compared with 68Ga-NODAGA-AE105. Anti-Cancer Agents in Medicinal Chemistry. PMID 29546835 DOI: 10.2174/1871520618666180316152618 |
0.356 |
|
2018 |
Vats K, Satpati AK, Sharma R, Sarma HD, Satpati D, Dash A. 177Lu-labeled cyclic Asn-Gly-Arg peptide tagged carbon nanospheres as tumor targeting radio-nanoprobes. Journal of Pharmaceutical and Biomedical Analysis. 152: 173-178. PMID 29414010 DOI: 10.1016/J.Jpba.2018.01.052 |
0.352 |
|
2018 |
Guleria M, Das T, Amirdhanayagam J, Sarma HD, Dash A. Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of 68Ga-Labeled Porphyrin: Impact on Pharmacokinetics and Tumor Uptake in a Mouse Model. Cancer Biotherapy & Radiopharmaceuticals. PMID 29373046 DOI: 10.1089/Cbr.2017.2337 |
0.409 |
|
2018 |
Kameswaran M, Pandey U, Gamre N, Shinto A, Subramanian S, Sarma HD, Kamleshwaran KK, Dash A. Ready-to-use 177 Lu-Rituximab injection for Non-Hodgkin’s Lymphoma: Formulation and preliminary clinical study Journal of Radioanalytical and Nuclear Chemistry. 318: 849-856. DOI: 10.1007/S10967-018-6042-7 |
0.328 |
|
2018 |
Mallia MB, Mathur A, Sharma R, Kumar C, Sarma HD, Banerjee S, Dash A. Preparation and preliminary evaluation of a tris-metronidazole- 99m Tc(CO) 3 complex for targeting tumor hypoxia Journal of Radioanalytical and Nuclear Chemistry. 317: 1203-1210. DOI: 10.1007/S10967-018-6012-0 |
0.405 |
|
2017 |
Satpati D, Sharma R, Kumar C, Sarma HD, Dash A. Ga-Chelation and comparative evaluation of ,'-bis-[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-,'-diacetic acid (HBED-CC) conjugated NGR and RGD peptides as tumor targeted molecular imaging probes. Medchemcomm. 8: 673-679. PMID 30108785 DOI: 10.1039/C7Md00006E |
0.384 |
|
2017 |
Chakravarty R, Chakraborty S, Khan MS, Ram R, Sarma HD, Dash A. An electrochemical approach for removal of radionuclidic contaminants of Eu from 153Sm for effective use in metastatic bone pain palliation. Nuclear Medicine and Biology. 58: 8-19. PMID 29309920 DOI: 10.1016/J.Nucmedbio.2017.11.010 |
0.305 |
|
2017 |
Vats K, Satpati D, Sharma R, Kumar C, Sarma HD, Banerjee S. Preparation and Comparative evaluation of (99m) Tc-HYNIC-cNGR and (99m) Tc-HYNIC-PEG2 -cNGR as Tumor Targeting Molecular Imaging Probes. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 29139598 DOI: 10.1002/Jlcr.3585 |
0.375 |
|
2017 |
Satpati D, Sharma R, Sarma HD, Dash A. Comparative Evaluation of (68) Ga-labeled NODAGA, DOTAGA and HBED-CC conjugated cNGR Peptide Chelates as Tumor Targeted Molecular Imaging Probes. Chemical Biology & Drug Design. PMID 29130625 DOI: 10.1111/Cbdd.13143 |
0.351 |
|
2017 |
Jain A, Kameswaran M, Pandey U, Prabhash K, Sarma HD, Dash A. (68)Ga labeled Erlotinib: A novel PET probe for imaging EGFR over-expressing tumors. Bioorganic & Medicinal Chemistry Letters. PMID 28893469 DOI: 10.1016/J.Bmcl.2017.08.065 |
0.364 |
|
2017 |
Sharma R, Kumar C, Mallia MB, Kameswaran M, Sarma HD, Banerjee S, Dash A. In Vitro Evaluation of (188)Re-HEDP: A Mechanistic View of Bone Pain Palliations. Cancer Biotherapy & Radiopharmaceuticals. PMID 28598690 DOI: 10.1089/Cbr.2017.2200 |
0.307 |
|
2017 |
Vats K, Satpati D, Sharma R, Kumar C, Sarma HD, Dash A. (99m) Tc-labeled NGR-Chlorambucil Conjugate, (99m) Tc-HYNIC-CLB-c(NGR) for Targeted Chemotherapy and Molecular Imaging. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 28545160 DOI: 10.1002/Jlcr.3522 |
0.372 |
|
2017 |
Chakraborty S, Vimalnath KV, Rajeswari A, Chakravarty R, Sarma HD, Radhakrishnan E, K K, Shinto AS, Dash A. A 'mix-and-use' approach for formulation of human clinical doses of (177) Lu-DOTMP at hospital radiopharmacy for management of pain arising from skeletal metastases. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 28477391 DOI: 10.1002/Jlcr.3517 |
0.327 |
|
2017 |
Satpati D, Shinto A, Kamaleshwaran KK, Sarma HD, Dash A. Preliminary PET/CT Imaging with Somatostatin Analogs [(68)Ga]DOTAGA-TATE and [(68)Ga]DOTAGA-TOC. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 28349291 DOI: 10.1007/S11307-017-1072-Z |
0.307 |
|
2017 |
Kameswaran M, Sarma HD, Dash A. Preclinical evaluation of (131)I-Bevacizumab - A prospective agent for radioimmunotherapy in VEGF expressing cancers. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 123: 109-113. PMID 28260607 DOI: 10.1016/J.Apradiso.2017.02.024 |
0.345 |
|
2017 |
Guleria M, Das T, Kumar C, Amirdhanayagam J, Sarma HD, Banerjee S. Preparation of clinical-scale (177) Lu-Rituximab: Optimization of protocols for conjugation, radiolabeling and freeze-dried kit formulation. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 28181275 DOI: 10.1002/Jlcr.3493 |
0.328 |
|
2017 |
Das T, Shinto A, Kamaleshwaran KK, Sarma HD, Mohammed SK, Mitra A, Lad S, Rajan MG, Banerjee S. Radiochemical studies, pre-clinical investigation and preliminary clinical evaluation of (170)Tm-EDTMP prepared using in-house freeze-dried EDTMP kit. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 122: 7-13. PMID 28088002 DOI: 10.1016/J.Apradiso.2016.12.058 |
0.315 |
|
2017 |
Ghosh S, Das T, Sarma HD, Banerjee S. Preparation and preliminary bioevaluation of 68Ga-oxine in lipiodol as a potential liver imaging agent Journal of Radioanalytical and Nuclear Chemistry. 311: 263-268. DOI: 10.1007/S10967-016-4985-0 |
0.359 |
|
2016 |
Vats K, Subramanian S, Mathur A, Sarma HD, Banerjee S. Radiosynthesis and evaluation of a (99m)Tc-folic acid radiotracer prepared using [(99m)TcN(PNP)](2+) metal fragment. Bioorganic & Medicinal Chemistry Letters. PMID 28174106 DOI: 10.1016/J.Bmcl.2016.03.090 |
0.369 |
|
2016 |
Jain A, Mathur A, Pandey U, Sarma HD, Dash A. (68)Ga labeled fatty acids for cardiac metabolic imaging: Influence of different bifunctional chelators. Bioorganic & Medicinal Chemistry Letters. PMID 27793567 DOI: 10.1016/J.Bmcl.2016.10.048 |
0.358 |
|
2016 |
Vats K, Satpati D, Sharma R, Sarma HD, Banerjee S. Synthesis and Comparative In Vivo Evaluation of (99m) Tc(CO)3 -labeled PEGylated and non-PEGylated cRGDfK Peptide Monomers. Chemical Biology & Drug Design. PMID 27561428 DOI: 10.1111/Cbdd.12844 |
0.396 |
|
2016 |
Rajeswari A, Vimalnath KV, Sarma HD, Shetty P, Mohammed SK, Nuwad J, Chakraborty S, Dash A. Hydroxyapatite (HA) microparticles labeled with (32)P - A promising option in the radiation synovectomy for inflamed joints. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 116: 85-91. PMID 27501139 DOI: 10.1016/J.Apradiso.2016.07.022 |
0.314 |
|
2016 |
Jain A, Mathur A, Pandey U, Bhatt J, Mukherjee A, Ram R, Sarma HD, Dash A. Synthesis and evaluation of a (68)Ga labeled folic acid derivative for targeting folate receptors. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 116: 77-84. PMID 27501138 DOI: 10.1016/J.Apradiso.2016.07.024 |
0.41 |
|
2016 |
Bhatt J, Mukherjee A, Korde A, Kumar M, Sarma HD, Dash A. Radiolabeling and Preliminary Evaluation of Ga-68 Labeled NODAGA-Ubiquicidin Fragments for Prospective Infection Imaging. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 27406090 DOI: 10.1007/S11307-016-0983-4 |
0.317 |
|
2016 |
Chakravarty R, Chakraborty S, Sarma HD, Nair KV, Rajeswari A, Dash A. (90) Y/(177) Lu-labelled Cetuximab immunoconjugates: radiochemistry optimization to clinical dose formulation. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 27264196 DOI: 10.1002/Jlcr.3413 |
0.367 |
|
2016 |
Kameswaran M, Pandey U, Gamre N, Vimalnath KV, Sarma HD, Dash A. Evaluation of (177)Lu-CHX-A''-DTPA-Bevacizumab as a radioimmunotherapy agent targeting VEGF expressing cancers. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 114: 196-201. PMID 27258216 DOI: 10.1016/J.Apradiso.2016.05.025 |
0.364 |
|
2016 |
Sakhare N, Das S, Mathur A, Mirapurkar S, Paradkar S, Sarma HD, Sachdev SS. Synthesis and characterization of a novel 99mTc analogue of ∗i-: M IBG showing affinity for nor-epinephrine transport positive tumors Rsc Advances. 6: 64902-64910. DOI: 10.1039/C6Ra11217J |
0.421 |
|
2016 |
Satpati D, Satpati A, Pamale Y, Kumar C, Sharma R, Sarma HD, Banerjee S. 177 Lu-labeled carbon nanospheres: a new entry in the field of targeted radionanomedicine Rsc Advances. 6: 50761-50769. DOI: 10.1039/C5Ra25502C |
0.362 |
|
2016 |
Guleria M, Ghosh S, Das T, Sarma HD, Banerjee S. Preparation and bioevaluation of [99mTcN]2+-labeled tetrameric complex of E-c(RGDfK)2 as a radiotracer for imaging αvβ3 integrins in tumors Journal of Radioanalytical and Nuclear Chemistry. 1-8. DOI: 10.1007/S10967-015-4680-6 |
0.41 |
|
2016 |
Vats K, Mallia MB, Mathur A, Sarma HD, Banerjee S. Synthesis and evaluation of a novel 99mTcN(PNP)-complex with metronidazole isocyanide ligand as a marker for tumor hypoxia Journal of Radioanalytical and Nuclear Chemistry. 308: 363-369. DOI: 10.1007/S10967-015-4526-2 |
0.399 |
|
2016 |
Pandey U, Mukherjee A, Jindal A, Gamre N, Korde A, Ram R, Sarma HD, Dash A. Preparation and evaluation of a single vial AMBA kit for 68Ga labeling with potential for imaging of GRP receptor-positive cancers Journal of Radioanalytical and Nuclear Chemistry. 307: 1115-1124. DOI: 10.1007/S10967-015-4290-3 |
0.348 |
|
2016 |
Guleria M, Das T, Sarma HD, Banerjee S. Synthesis and bioevaluation of a 177Lu-labeled unsymmetrical cationic porphyrin derivative as a tumor targeting agent Journal of Radioanalytical and Nuclear Chemistry. 307: 1537-1544. DOI: 10.1007/S10967-015-4276-1 |
0.397 |
|
2015 |
Mallia MB, Mittal S, Sarma HD, Banerjee S. Modulation of in vivo distribution through chelator: Synthesis and evaluation of a 2-nitroimidazole-dipicolylamine-(99m)Tc(CO)3 complex for detecting tumor hypoxia. Bioorganic & Medicinal Chemistry Letters. PMID 26615889 DOI: 10.1016/J.Bmcl.2015.11.034 |
0.379 |
|
2015 |
Chakraborty S, Chakravarty R, Vatsa R, Bhusari P, Sarma HD, Shukla J, Mittal BR, Dash A. Toward realization of 'mix-and-use' approach in (68)Ga radiopharmacy: preparation, evaluation and preliminary clinical utilization of (68)Ga-labeled NODAGA-coupled RGD peptide derivative. Nuclear Medicine and Biology. PMID 26527030 DOI: 10.1016/J.Nucmedbio.2015.09.010 |
0.381 |
|
2015 |
Mukherjee A, Lohar S, Dash A, Sarma HD, Samuel G, Korde A. Single vial kit formulation of DOTATATE for preparation of (177) Lu-labeled therapeutic radiopharmaceutical at hospital radiopharmacy. Journal of Labelled Compounds & Radiopharmaceuticals. 58: 166-72. PMID 25765604 DOI: 10.1002/Jlcr.3267 |
0.351 |
|
2015 |
Vimalnath KV, Chakraborty S, Rajeswari A, Sarma HD, Nuwad J, Pandey U, Kamaleshwaran K, Shinto A, Dash A. Radiochemistry, pre-clinical studies and first clinical investigation of 90Y-labeled hydroxyapatite (HA) particles prepared utilizing 90Y produced by (n,γ) route. Nuclear Medicine and Biology. 42: 455-464. PMID 25659856 DOI: 10.1016/J.Nucmedbio.2015.01.006 |
0.329 |
|
2015 |
Mallia MB, Mathur A, Sarma HD, Banerjee S. A (99m)Tc-labeled misonidazole analogue: step toward a (99m)Tc-alternative to [18F]fluromisonidazole for detecting tumor hypoxia. Cancer Biotherapy & Radiopharmaceuticals. 30: 79-86. PMID 25569675 DOI: 10.1089/Cbr.2014.1705 |
0.356 |
|
2015 |
Chakravarty R, Chakraborty S, Vimalnath KV, Shetty P, Sarma HD, Hassan PA, Dash A. 64 CuCl2 produced by direct neutron activation route as a cost-effective probe for cancer imaging: the journey has begun Rsc Advances. 5: 91723-91733. DOI: 10.1039/C5Ra17266G |
0.374 |
|
2015 |
Mathur A, Sharma AK, Murhekar VV, Mallia MB, Pawade S, Sarma HD, Chaudhari P, Sachdev SS, Banerjee S. Syntheses and biological evaluation of 99mTc-HYNIC-fatty acid complexes for myocardial imaging Rsc Advances. 5: 93374-93385. DOI: 10.1039/C5Ra12683E |
0.355 |
|
2015 |
Jain A, Subramanian S, Pandey U, Sarma HD, Ram R, Dash A. In-house preparation of macroaggregated albumin (MAA) for 68Ga labeling and its comparison with commercially available MAA Journal of Radioanalytical and Nuclear Chemistry. DOI: 10.1007/S10967-015-4509-3 |
0.331 |
|
2015 |
Pandey U, Gamre N, Kumar Y, Shetty P, Sarma HD, Dash A. A systematic evaluation of the potential of PCTA-NCS ligand as a bifunctional chelating agent for design of 177Lu radiopharmaceuticals Journal of Radioanalytical and Nuclear Chemistry. DOI: 10.1007/S10967-015-4281-4 |
0.354 |
|
2015 |
Bhadwal M, Mallia MB, Sarma HD, Banerjee S. Neutral 99mTc(CO)3 complexes of “clicked” nitroimidazoles for the detection of tumor hypoxia Journal of Radioanalytical and Nuclear Chemistry. DOI: 10.1007/S10967-015-4135-0 |
0.406 |
|
2014 |
Kameswaran M, Pandey U, Sarma HD, Samuel G. Preparation of 99m Tc carbonyl DTPA-bevacizumab and its bioevaluation in a melanoma model Annals of Nuclear Medicine. 28: 911-916. PMID 25038907 DOI: 10.1007/S12149-014-0887-9 |
0.305 |
|
2014 |
Satpati D, Korde A, Sarma HD, Banerjee S. Radiosynthesis and biological evaluation of 68Ga-labeled colchicine conjugates. Cancer Biotherapy & Radiopharmaceuticals. 29: 251-6. PMID 24983126 DOI: 10.1089/Cbr.2014.1621 |
0.363 |
|
2014 |
Jindal A, Mathur A, Pandey U, Sarma HD, Chaudhari P, Dash A. Development of 68Ga-labeled fatty acids for their potential use in cardiac metabolic imaging. Journal of Labelled Compounds & Radiopharmaceuticals. 57: 463-9. PMID 24966158 DOI: 10.1002/Jlcr.3205 |
0.357 |
|
2014 |
Chakraborty S, Vimalnath KV, Rajeswari A, Shinto A, Sarma HD, Kamaleshwaran K, Thirumalaisamy P, Dash A. Preparation, evaluation, and first clinical use of 177Lu-labeled hydroxyapatite (HA) particles in the treatment of rheumatoid arthritis: utility of cold kits for convenient dose formulation at hospital radiopharmacy. Journal of Labelled Compounds and Radiopharmaceuticals. 57: 453-462. PMID 24966157 DOI: 10.1002/Jlcr.3202 |
0.32 |
|
2014 |
Das T, Banerjee S, Shinto A, Kamaleshwaran KK, Sarma HD. Preparation of therapeutic dose of 177Lu-DOTA-TATE using a novel single vial freeze-dried kit: a comparison with 'in-situ' preparation at hospital radiopharmacy. Current Radiopharmaceuticals. 7: 12-9. PMID 24934713 DOI: 10.2174/1874471007666140605100812 |
0.308 |
|
2014 |
Mallia MB, Subramanian S, Mathur A, Sarma HD, Banerjee S. A study on nitroimidazole-99mTc(CO)3 complexes as hypoxia marker: some observations towards possible improvement in in vivo efficacy. Nuclear Medicine and Biology. 41: 600-10. PMID 24856280 DOI: 10.1016/J.Nucmedbio.2014.04.103 |
0.393 |
|
2014 |
Mukherjee A, Sahoo S, Sarma HD, Chakraborti CK, Samuel G. Preparation and evaluation of three mucoadhesive dosage forms using (99m)Tc-Ofloxacin. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 89: 192-8. PMID 24681624 DOI: 10.1016/J.Apradiso.2014.01.031 |
0.31 |
|
2014 |
Pandey U, Kameswaran M, Sarma HD, Samuel G. 99mTc carbonyl DTPA–Rituximab: Preparation and preliminary bioevaluation Applied Radiation and Isotopes. 86: 52-56. PMID 24486518 DOI: 10.1016/J.Apradiso.2013.12.036 |
0.312 |
|
2014 |
Mukherjee A, Pandey U, Chakravarty R, Sarma HD, Dash A. Development of single vial kits for preparation of (68)Ga-labelled peptides for PET imaging of neuroendocrine tumours. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 16: 550-7. PMID 24477930 DOI: 10.1007/S11307-014-0719-2 |
0.339 |
|
2014 |
Chakraborty S, Chakravarty R, Sarma HD, Pillai MRA, Ashutosh D. Utilization of a novel electrochemical 90Sr/90Y generator for the preparation of 90Y-labeled RGD peptide dimer in clinically relevant dose Radiochimica Acta. 102: 523-534. DOI: 10.1515/Ract-2013-2158 |
0.301 |
|
2014 |
Vimalnath KV, Rajeswari A, Sarma HD, Chakraborty S. 141Ce-DOTMP: A theranostic agent for metastatic bone tumor Nuclear Medicine and Biology. 41: 634. DOI: 10.1016/J.Nucmedbio.2014.05.013 |
0.312 |
|
2014 |
Mukherjee A, Pandey U, Chakravarty R, Sarma HD, Dash A. Single vial kit formulation for preparation of PET radiopharmaceutical: 68Ga-DOTA-TOC Journal of Radioanalytical and Nuclear Chemistry. 302: 1253-1258. DOI: 10.1007/S10967-014-3643-7 |
0.318 |
|
2014 |
Satpati D, Korde A, Sarma HD, Banerjee S. Synthesis and evaluation of a phenylbenzothiazole-based 99mTc(CO)3-radiotracer for possible application in imaging of β-amyloid plaques in Alzheimer’s disease Journal of Radioanalytical and Nuclear Chemistry. 302: 1339-1344. DOI: 10.1007/S10967-014-3548-5 |
0.307 |
|
2014 |
Das T, Bhadwal M, Sarma HD, Banerjee S. Formulation and radiochemical evaluation of a freeze-dried mixed peptide kit for the preparation of 68Ga-labeled peptides for PET imaging of somatostatin receptor positive neuroendocrine cancers Journal of Radioanalytical and Nuclear Chemistry. 302: 1259-1264. DOI: 10.1007/S10967-014-3537-8 |
0.329 |
|
2014 |
Mukherjee A, Korde A, Sarma HD, Samuel G. Single vial formulation for theranostic radiopharmaceutical preparation Journal of Radioanalytical and Nuclear Chemistry. 302: 889-894. DOI: 10.1007/S10967-014-3308-6 |
0.367 |
|
2014 |
Das T, Bhadwal M, Banerjee S, Sarma HD, Shinto A, Kamaleshwaran KK. Preparation of DOTA-TATE and DOTA-NOC freeze-dried kits for formulation of patient doses of 177Lu-labeled agents and their comparison for peptide receptor radionuclide therapy application Journal of Radioanalytical and Nuclear Chemistry. 299: 1389-1398. DOI: 10.1007/S10967-013-2894-Z |
0.34 |
|
2013 |
Vats K, Das T, Sarma HD, Banerjee S, Pillai MR. Radiolabeling, stability studies, and pharmacokinetic evaluation of thulium-170-labeled acyclic and cyclic polyaminopolyphosphonic acids. Cancer Biotherapy & Radiopharmaceuticals. 28: 737-45. PMID 23931111 DOI: 10.1089/Cbr.2013.1475 |
0.313 |
|
2013 |
Chakraborty S, Sarma HD, Vimalnath KV, Pillai MR. Tracer level radiochemistry to clinical dose preparation of (177)Lu-labeled cyclic RGD peptide dimer. Nuclear Medicine and Biology. 40: 946-54. PMID 23850487 DOI: 10.1016/J.Nucmedbio.2013.05.011 |
0.386 |
|
2013 |
Mittal S, Bhadwal M, Das T, Sarma HD, Chakravarty R, Dash A, Banerjee S, Pillai MR. Synthesis and biological evaluation of 90Y-labeled porphyrin-DOTA conjugate: a potential molecule for targeted tumor therapy. Cancer Biotherapy & Radiopharmaceuticals. 28: 651-6. PMID 23837800 DOI: 10.1089/Cbr.2013.1512 |
0.387 |
|
2013 |
Vimalnath KV, Shetty P, Chakraborty S, Das T, Chirayil V, Sarma HD, Jagadeesan KC, Joshi PV. Practicality of production of ³²P by direct neutron activation for its utilization in bone pain palliation as Na₃[³²P]PO₄. Cancer Biotherapy & Radiopharmaceuticals. 28: 423-8. PMID 23611187 DOI: 10.1089/Cbr.2012.1335 |
0.31 |
|
2013 |
Mittal S, Bhadwal M, Chakraborty S, Sarma HD, Banerjee S, Pillai MR. A novel concept of radiosynthesis of a (99m)Tc-labeled dimeric RGD peptide as a potential radiotracer for tumor imaging. Bioorganic & Medicinal Chemistry Letters. 23: 1808-12. PMID 23414841 DOI: 10.1016/J.Bmcl.2013.01.036 |
0.396 |
|
2013 |
Mathur A, Mallia MB, Banerjee S, Sarma HD, Pillai MR. Preparation and evaluation of a ⁹⁹mTcN-PNP complex of sanazole analogue for detecting tumor hypoxia. Bioorganic & Medicinal Chemistry Letters. 23: 1394-7. PMID 23375795 DOI: 10.1016/J.Bmcl.2012.12.079 |
0.395 |
|
2013 |
Chakraborty S, Chakravarty R, Sarma HD, Dash A, Pillai MR. The practicality of nanoceria-PAN-based (68)Ge/(68)Ga generator toward preparation of (68)Ga-labeled cyclic RGD dimer as a potential PET radiotracer for tumor imaging. Cancer Biotherapy & Radiopharmaceuticals. 28: 77-83. PMID 22967229 DOI: 10.1089/Cbr.2012.1252 |
0.397 |
|
2012 |
Mallia MB, Kumar C, Mathur A, Sarma HD, Banerjee S. On the structural modification of 2-nitroimidazole-(99m)Tc(CO)(3) complex, a hypoxia marker, for improving in vivo pharmacokinetics. Nuclear Medicine and Biology. 39: 1236-42. PMID 22938843 DOI: 10.1016/J.Nucmedbio.2012.07.005 |
0.38 |
|
2012 |
Das T, Chakraborty S, Sarma HD, Banerjee S. 109Pd labeled 5,10,15,20-tetrakis[4-carboxymethyleneoxyphenyl]porphyrin: a potential agent for targeted tumor therapy. Current Radiopharmaceuticals. 5: 340-7. PMID 22935057 DOI: 10.2174/1874471011205040340 |
0.329 |
|
2012 |
Bhadwal M, Satpati D, Singhal S, Sarma HD, Venkatesh M, Banerjee S. Preparation of 99mTc(CO)3-Carboxymethylthioethyl iminodiacetic acid and evaluation as a potential renal imaging agent. Current Radiopharmaceuticals. 5: 65-70. PMID 21864246 DOI: 10.2174/1874471011205010065 |
0.366 |
|
2012 |
Chakraborty S, Das T, Sarma HD, Banerjee S. Effect of lipophilicity on biological properties of 109Pd-porphyrin complexes: a preliminary investigation Journal of Porphyrins and Phthalocyanines. 16: 64-71. DOI: 10.1142/S1088424611004427 |
0.314 |
|
2011 |
Sarma HD, Das T, Banerjee S, Venkatesh M, Vidyasagar PB, Mishra KP. Studies on efficacy of a novel 177Lu-labeled porphyrin derivative in regression of tumors in mouse model. Current Radiopharmaceuticals. 4: 150-60. PMID 22191655 DOI: 10.2174/1874471011104020150 |
0.386 |
|
2011 |
Mathur A, Mallia MB, Sarma HD, Banerjee S, Venkatesh M. Synthesis, radiolabeling and evaluation of a new positively charged 99mTc‐labeled fatty acid derivative for myocardial imaging Journal of Labelled Compounds and Radiopharmaceuticals. 54: 150-156. DOI: 10.1002/Jlcr.1836 |
0.341 |
|
2010 |
Dhyani MV, Satpati D, Korde A, Sarma HD, Kumar C, Banerjee S. Preparation and preliminary bioevaluation of 99mTc(CO)3-11β-progesterone derivative prepared via click chemistry route. Nuclear Medicine and Biology. 37: 997-1004. PMID 21055631 DOI: 10.1016/J.Nucmedbio.2010.05.005 |
0.367 |
|
2010 |
Das T, Chakraborty S, Sarma HD, Banerjee S, Venakatesh M. A novel 177Lu-labeled porphyrin for possible use in targeted tumor therapy. Nuclear Medicine and Biology. 37: 655-63. PMID 20610170 DOI: 10.1016/J.Nucmedbio.2010.02.007 |
0.371 |
|
2010 |
Sarma HD, Das T, Banerjee S, Venkatesh M, Vidyasagar PB, Mishra KP. Biologic evaluation of a novel 188Re-labeled porphyrin in mice tumor model. Cancer Biotherapy & Radiopharmaceuticals. 25: 47-54. PMID 20187796 DOI: 10.1089/Cbr.2009.0675 |
0.414 |
|
2010 |
Mallia MB, Mathur A, Banerjee S, Sarma HD, Venkatesh M. Synthesis, radiolabeling and evalution of 99mTc(CO)3-labeled misonidazole analogue to target tumor hypoxia Nuclear Medicine and Biology. 37: 682-683. DOI: 10.1016/J.Nucmedbio.2010.04.078 |
0.357 |
|
2010 |
Mathur A, Mallia MB, Sarma HD, Banerjee S, Venkatesh M. Evaluation of new positively charged 11- and 12-carbon 99mTc-labeled fatty acid derivatives for myocardial imaging Journal of Labelled Compounds and Radiopharmaceuticals. 53: 580-585. DOI: 10.1002/Jlcr.1784 |
0.362 |
|
2010 |
Mallia MB, Subramanian S, Mathur A, Sarma HD, Venkatesh M, Banerjee S. Synthesis and evaluation of 2‐, 4‐, 5‐substituted nitroimidazole‐iminodiacetic acid‐99mTc(CO)3 complexes to target hypoxic tumors Journal of Labelled Compounds and Radiopharmaceuticals. 53: 535-542. DOI: 10.1002/Jlcr.1754 |
0.411 |
|
2010 |
Satpati D, Bapat K, Sarma HD, Venkatesh M, Banerjee S. Synthesis, characterization and biological activity of 99mTc‐labeled piperidine analogues targeting sigma receptors Journal of Labelled Compounds and Radiopharmaceuticals. 53: 198-204. DOI: 10.1002/Jlcr.1750 |
0.347 |
|
2009 |
Satpati D, Pandey U, Sarma HD, Venkatesh M, Banerjee S. Preparation and evaluation of 99mTc(CO)3-labeled pentadecanoic acid derivative and its suspension in lipiodol. Cancer Biotherapy & Radiopharmaceuticals. 24: 503-7. PMID 19694585 DOI: 10.1089/Cbr.2008.0602 |
0.362 |
|
2009 |
Das T, Chakraborty S, Sarma HD, Venkatesh M, Banerjee S. 166Ho-labeled hydroxyapatite particles: a possible agent for liver cancer therapy. Cancer Biotherapy & Radiopharmaceuticals. 24: 7-14. PMID 19216630 DOI: 10.1089/Cbr.2008.0545 |
0.303 |
|
2008 |
Satpati D, Korde A, Kothari K, Sarma HD, Venkatesh M, Banerjee S. Preparation and in-vivo evaluation of (188)Re(CO)(3)-colchicine complex for use as tumor-targeting agent. Cancer Biotherapy & Radiopharmaceuticals. 23: 741-8. PMID 19111049 DOI: 10.1089/Cbr.2008.0509 |
0.433 |
|
2008 |
Mallia MB, Subramanian S, Mathur A, Sarma HD, Venkatesh M, Banerjee S. On the isolation and evaluation of a novel unsubstituted 5-nitroimidazole derivative as an agent to target tumor hypoxia. Bioorganic & Medicinal Chemistry Letters. 18: 5233-7. PMID 18774708 DOI: 10.1016/J.Bmcl.2008.08.069 |
0.434 |
|
2008 |
Mathur A, Subramanian S, Mallia MB, Banerjee S, Samuel G, Sarma HD, Venkatesh M. Synthesis and bio-evaluation of a new fatty acid derivative for myocardial imaging. Bioorganic & Medicinal Chemistry. 16: 7927-31. PMID 18701306 DOI: 10.1016/J.Bmc.2008.07.074 |
0.358 |
|
2008 |
Chakraborty S, Das T, Banerjee S, Balogh L, Chaudhari PR, Sarma HD, Polyák A, Máthé D, Venkatesh M, Janoki G, Pillai MR. 177Lu-EDTMP: a viable bone pain palliative in skeletal metastasis. Cancer Biotherapy & Radiopharmaceuticals. 23: 202-13. PMID 18454689 DOI: 10.1089/Cbr.2007.374 |
0.355 |
|
2008 |
Chakraborty S, Das T, Sarma HD, Venkatesh M, Banerjee S. Comparative studies of 177Lu-EDTMP and 177Lu-DOTMP as potential agents for palliative radiotherapy of bone metastasis. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 66: 1196-205. PMID 18372188 DOI: 10.1016/J.Apradiso.2008.02.061 |
0.338 |
|
2008 |
Satpati D, Bapat K, Sarma HD, Kothari K, Venkatesh M, Banerjee S. Synthesis of 99mTc-nitrido heterocomplex of piperidine and in vitro and in vivo evaluation of its affinity for sigma receptors. Cancer Biotherapy & Radiopharmaceuticals. 23: 34-42. PMID 18298327 DOI: 10.1089/Cbr.2007.763 |
0.388 |
|
2008 |
Das T, Chakraborty S, Sarma HD, Banerjee S. A novel [109Pd] palladium labeled porphyrin for possible use in targeted radiotherapy Radiochimica Acta. 96: 427-433. DOI: 10.1524/Ract.2008.1505 |
0.368 |
|
2008 |
Das T, Chakraborty S, Sarma HD, Banerjee S. 177Lu-DOTMP : A viable agent for palliative radiotherapy of painful bone metastasis Radiochimica Acta. 96: 55-61. DOI: 10.1524/Ract.2008.1464 |
0.385 |
|
2008 |
Pandey U, Mukherjee A, Samuel G, Banerjee S, Sarma HD, Venkatesh M. Preparation of 125I-Lanreotide and its biodistribution in murine model of melanoma Journal of Radioanalytical and Nuclear Chemistry. 275: 243-246. DOI: 10.1007/S10967-007-6941-5 |
0.371 |
|
2008 |
Mallia MB, Subramanian S, Mathur A, Sarma HD, Venkatesh M, Banerjee S. Comparing hypoxia‐targeting potential of 99mTc(CO)3‐labeled 2‐nitro and 4‐nitroimidazole Journal of Labelled Compounds and Radiopharmaceuticals. 51: 308-313. DOI: 10.1002/Jlcr.1525 |
0.433 |
|
2007 |
Pandey U, Bapat K, Samuel G, Sarma HD, Venkatesh M. Potential of radioiodinated anti cancer compounds of natural origin for cancer therapy Journal of Radioanalytical and Nuclear Chemistry. 273: 725-728. DOI: 10.1007/S10967-007-0937-Z |
0.34 |
|
2007 |
Pandey U, Banerjee S, Mukherjee A, Sarma HD, Venkatesh M. 90Y-DOTA-Lanreotide: A potential agent for targeted therapy Journal of Radioanalytical and Nuclear Chemistry. 273: 719-723. DOI: 10.1007/S10967-007-0936-0 |
0.402 |
|
2006 |
Mallia MB, Subramanian S, Banerjee S, Sarma HD, Venkatesh M. Evaluation of 99mTc(CO)3 complex of 2-methyl-5-nitroimidazole as an agent for targeting tumor hypoxia. Bioorganic & Medicinal Chemistry. 14: 7666-70. PMID 16949291 DOI: 10.1016/J.Bmc.2006.08.011 |
0.426 |
|
2006 |
Pandey U, Sarma HD, Ingle AD, Kulloli BS, Samuel G, Venkatesh M. Radioactive skin bandages incorporating 32P for treatment of superficial tumors. Cancer Biotherapy and Radiopharmaceuticals. 21: 257-262. PMID 16918302 DOI: 10.1089/Cbr.2006.21.257 |
0.332 |
|
2006 |
Chakraborty S, Das T, Banerjee S, Sarma HD, Venkatesh M. Preparation and preliminary biological evaluation of 177Lu-labelled hydroxyapatite as a promising agent for radiation synovectomy of small joints. Nuclear Medicine Communications. 27: 661-8. PMID 16829766 DOI: 10.1097/00006231-200608000-00008 |
0.302 |
|
2006 |
Chakraborty S, Das T, Banerjee S, Subramanian S, Sarma HD, Venkatesh M. 175Yb-labeled hydroxyapatite: a potential agent for use in radiation synovectomy of small joints. Nuclear Medicine and Biology. 33: 585-91. PMID 16720253 DOI: 10.1016/J.Nucmedbio.2006.02.004 |
0.326 |
|
2006 |
Mathur A, Mallia MB, Subramanian S, Banerjee S, Sarma HD, Kothari K, Venkatesh M. Preparation and in vivo evaluation of (99m)TcN-tertiary butyl xanthate as a potential myocardial agent. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 64: 663-7. PMID 16436328 DOI: 10.1016/J.Apradiso.2005.12.008 |
0.344 |
|
2006 |
Chakraborty S, Das T, Banerjee S, Sarma HD, Venkatesh M. Preparation and preliminary biological evaluation of a (166)Ho labeled polyazamacrocycle for possible use as an intravascular brachytherapy (IVBT) agent. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 64: 462-9. PMID 16352432 DOI: 10.1016/J.Apradiso.2005.11.001 |
0.378 |
|
2006 |
Mallia MB, Mathur A, Subramanian S, Banerjee S, Kothari K, Koiry SP, Sarma HD, Venkatesh M. Synthesis and evaluation of ether containing 99mTc-nitrido dithiocarbamate complexes as brain perfusion imaging agent. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 64: 361-7. PMID 16293419 DOI: 10.1016/J.Apradiso.2005.09.003 |
0.352 |
|
2006 |
Korde A, Satpati D, Mathur A, Mallia M, Banerjee S, Kothari K, Sarma HD, Choudhari P, Venkatesh M. 99mTc-labeling of colchicine using [99mTc(CO)3(H2O)3]+ and [99mTc triple bond N]2+ core for the preparation of potential tumor-targeting agents. Bioorganic & Medicinal Chemistry. 14: 793-9. PMID 16289854 DOI: 10.1016/J.Bmc.2005.09.006 |
0.375 |
|
2006 |
Das T, Chakraborty S, Banerjee S, Sarma HD, Samuel G, Venkatesh M. Preparation and preliminary biological evaluation of a 177Lu labeled nitroimidazole derivative for possible use in targeted tumor therapy Radiochimica Acta. 94: 375-380. DOI: 10.1524/Ract.2006.94.6.375 |
0.423 |
|
2006 |
Mathur A, Mallia MB, Subramanian S, Banerjee S, Kothari K, Sarma HD, Venkatesh M. Synthesis and bio evaluation of a new fatty acid derivative labelled with technetium-99m Journal of Labelled Compounds and Radiopharmaceuticals. 49: 1053-1060. DOI: 10.1002/Jlcr.1130 |
0.395 |
|
2005 |
Mathur A, Mallia MB, Subramanian S, Banerjee S, Kothari K, Dhotare B, Sarma HD, Venkatesh M. 99mTcN complexes of tert-butyl dithiocarbamate and methoxyisobutyl dithiocarbamate as myocardial and brain imaging agents. Nuclear Medicine Communications. 26: 1013-9. PMID 16208180 DOI: 10.1097/01.Mnm.0000183793.51474.2F |
0.368 |
|
2005 |
Mallia MB, Mathur A, Subramanian S, Banerjee S, Sarma HD, Venkatesh M. A novel [99mTc[triple bond]N]2+ complex of metronidazole xanthate as a potential agent for targeting hypoxia. Bioorganic & Medicinal Chemistry Letters. 15: 3398-401. PMID 16044527 DOI: 10.1016/J.Bmcl.2005.05.030 |
0.406 |
|
2005 |
Bapat K, Chintalwar GJ, Pandey U, Thakur VS, Sarma HD, Samuel G, Pillai MR, Chattopadhyay S, Venkatesh M. Preparation and in vitro evaluation of radioiodinated bakuchiol as an anti tumor agent. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 62: 389-93. PMID 15607914 DOI: 10.1016/J.Apradiso.2004.07.007 |
0.348 |
|
2004 |
Chakraborty S, Das T, Banerjee S, Chaudhari PR, Sarma HD, Venkatesh M, Pillai MR. Preparation and biological evaluation of 153Sm-DOTMP as a potential agent for bone pain palliation. Nuclear Medicine Communications. 25: 1169-76. PMID 15640774 DOI: 10.1097/00006231-200412000-00003 |
0.319 |
|
2004 |
Das T, Chakraborty S, Banerjee S, Mukherjee A, Samuel G, Sarma HD, Nair CK, Kagiya VT, Venkatesh M. Preparation and preliminary biological evaluation of a 177Lu labeled sanazole derivative for possible use in targeting tumor hypoxia. Bioorganic & Medicinal Chemistry. 12: 6077-84. PMID 15519153 DOI: 10.1016/J.Bmc.2004.09.007 |
0.439 |
|
2004 |
Mathew B, Chakraborty S, Das T, Sarma HD, Banerjee S, Samuel G, Venkatesh M, Pillai MR. 175Yb labeled polyaminophosphonates as potential agents for bone pain palliation. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 60: 635-42. PMID 15082040 DOI: 10.1016/J.Apradiso.2003.09.016 |
0.36 |
|
2003 |
Das T, Banerjee S, Samuel G, Sarma HD, Korde A, Venkatesh M, Pillai MR. 99mTc-labeling studies of a modified metronidazole and its biodistribution in tumor bearing animal models. Nuclear Medicine and Biology. 30: 127-34. PMID 12623111 DOI: 10.1016/S0969-8051(02)00388-8 |
0.427 |
|
2003 |
Das T, Chakraborty S, Banerjee S, Samuel G, Sarma HD, Venkatesh M, Pillai MRA. Preparation and animal biodistribution of 166Ho labeled DOTA for possible use in intravascular radiation therapy (IVRT) Journal of Labelled Compounds and Radiopharmaceuticals. 46: 197-209. DOI: 10.1002/Jlcr.657 |
0.365 |
|
2002 |
Pandey U, Mukherjee A, Sarma HD, Das T, Pillai MR, Venkatesh M. Evaluation of 90Y-DTPA and 90Y-DOTA for potential application in intra-vascular radionuclide therapy. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 57: 313-8. PMID 12201136 DOI: 10.1016/S0969-8043(02)00103-3 |
0.329 |
|
2002 |
Das T, Chakraborty S, Unni PR, Banerjee S, Samuel G, Sarma HD, Venkatesh M, Pillai MR. 177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 57: 177-84. PMID 12150276 DOI: 10.1016/S0969-8043(02)00104-5 |
0.35 |
|
2002 |
Chakraborty S, Das T, Unni PR, Sarma HD, Samuel G, Banerjee S, Venkatesh M, Ramamoorthy N, Pillai MR. 177Lu labelled polyaminophosphonates as potential agents for bone pain palliation. Nuclear Medicine Communications. 23: 67-74. PMID 11748440 DOI: 10.1097/00006231-200201000-00011 |
0.366 |
|
2002 |
Kothari K, Satpati D, Mukherjee A, Sarma HD, Venkatesh M, Pillai MRA. Kidney uptake of 186/188Re(V)-DMSA is significantly reduced when the reducing agent is changed from stannous ion to metabisulfite Journal of Labelled Compounds and Radiopharmaceuticals. 45: 675-686. DOI: 10.1002/Jlcr.598 |
0.313 |
|
2001 |
Banerjee S, Das T, Samuel G, Sarma HD, Venkatesh M, Pillai MRA. A novel [186/188Re]-labelled porphyrin for targeted radiotherapy. Nuclear Medicine Communications. 22: 1101-1107. PMID 11567183 DOI: 10.1097/00006231-200110000-00008 |
0.365 |
|
2001 |
Kothari K, Samuel G, Banerjee S, Unni PR, Sarma HD, Chaudhari PR, Unnikrishnan TP, Pillai MRA. 186Re-1,4,8,11-tetraaza cyclotetradecyl-1,4,8,11-tetramethylene phosphonic acid: a novel agent for possible use in metastatic bone-pain palliation. Nuclear Medicine and Biology. 28: 709-717. PMID 11518653 DOI: 10.1016/S0969-8051(01)00224-4 |
0.386 |
|
2001 |
Chakraborty S, Unni PR, Banerjee S, Samuel G, Das T, Sarma HD, Ramamoorthy N, Pillai MRA. Potential 166Ho radiopharmaceuticals for intravascular radiation therapy (IVRT)-I : [166Ho] holmium labeled ethylene dicysteine Nuclear Medicine and Biology. 28: 309-317. PMID 11323243 DOI: 10.1016/S0969-8051(00)00197-9 |
0.353 |
|
2001 |
Banerjee S, Samuel G, Kothari K, Unni PR, Sarma HD, Pillai MRA. Tc-99m and Re-186 complexes of tetraphosphonate ligands and their biodistribution pattern in animal models. Nuclear Medicine and Biology. 28: 205-213. PMID 11295431 DOI: 10.1016/S0969-8051(00)00173-6 |
0.343 |
|
2001 |
Das T, Banerjee S, Samuel G, Sarma HD, Ramamoorthy N, Pillai MR. 188Re-ethylene dicysteine: a novel agent for possible use in endovascular radiation therapy. Nuclear Medicine Communications. 21: 939-45. PMID 11130335 DOI: 10.1097/00006231-200010000-00008 |
0.375 |
|
2001 |
Saidi M, Kothari K, Pillai MRA, Hassan A, Sarma HD, Chaudhari PR, Unnikrishnan TP, Korde A, Azzouz Z. Cyclopentadienyl technetium (99mTc) tricarbonyl piperidine conjugates: biodistribution and imaging studies Journal of Labelled Compounds and Radiopharmaceuticals. 44: 603-618. DOI: 10.1002/Jlcr.491 |
0.351 |
|
2000 |
Das T, Banerjee S, Samuel G, Kothari K, Unni PR, Sarma HD, Ramamoorthy N, Pillai MR. [(186/188)Re] rhenium-ethylene dicysteine (Re-Ec): preparation and evaluation for possible use in endovascular brachytherapy. Nuclear Medicine and Biology. 27: 189-97. PMID 10773549 DOI: 10.1016/S0969-8051(99)00097-9 |
0.358 |
|
2000 |
Kothari K, Banerjee S, Sarma HD, Pillai MR. Syntheses and radiolabeling of cysteine-oximes and pharmacological behaviour of their 99mTc complexes. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 52: 69-76. PMID 10670925 DOI: 10.1016/S0969-8043(99)00121-9 |
0.311 |
|
2000 |
Banerjee S, Samuel G, Sarma HD, Pillai MRA. Syntheses and radiochemical studies of 99mTc-complexes of polydentate tris-amineoxime ligands Journal of Labelled Compounds and Radiopharmaceuticals. 43: 1335-1344. DOI: 10.1002/1099-1344(200012)43:14<1335::Aid-Jlcr423>3.0.Co;2-T |
0.332 |
|
1999 |
Pillai MRA, Kothari K, Banerjee S, Samuel G, Suresh M, Sarma HD, Jurisson S. Radiochemical studies of 99mTc complexes of modified cysteine ligands and bifunctional chelating agents Nuclear Medicine and Biology. 26: 555-561. PMID 10473195 DOI: 10.1016/S0969-8051(99)00009-8 |
0.325 |
|
1999 |
Pillai MRA, Samuel G, Banerjee S, Mathew B, Sarma HD, Jurisson S. Technetium-99m complexes of polydentate amine-pyrrole and amine- thiophene ligands Nuclear Medicine and Biology. 26: 69-77. PMID 10096504 DOI: 10.1016/S0969-8051(98)00051-1 |
0.336 |
|
1997 |
Grace S, Meera V, Balakrishnan SA, Sarma HD. Preparation of125I labeled testosterone derivatives for use in radioimmunoassays Journal of Radioanalytical and Nuclear Chemistry. 223: 83-87. DOI: 10.1007/Bf02223368 |
0.313 |
|
Show low-probability matches. |